The annual lecture focused on biotherapies. It covered therapeutic developments in antibodies (2 lectures), gene therapies (2 lectures) and cell therapies (2 lectures). The lecture was accompanied by a seminar organized jointly with the Chair of Human Genetics (J.-L. Mandel) on the theme of new therapies for monogenic diseases. The seminar was held at the Collège de France on Thursday, April 16 and Friday, April 17, 2015.
In recent years, biotherapies have accounted for more than half of all drugs on the market. They are revolutionizing certain fields of medicine, moving drug research away from classical chemistry (which is still of great interest) towards the use of recombinant proteins, including monoclonal antibodies, genes and cells. These are the issues addressed in the cycle of lectures on biotherapies.